Thompson Davis & Co’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Thompson Davis & Co’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-250	Closed	-$3K	–	1364
2014 Q3	$3K	Buy	+250	New	+$3.73K	﹤0.01%	1038
2014 Q2	–	Sell	-250	Closed	-$3K	–	959
2014 Q1	$3K	Buy	+250	New	+$3.27K	0.01%	740

Thompson Davis & Co's DRTX Position: Q4 2014 in Review

Thompson Davis & Co sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 250 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in DRTX in Q1 2014 and held it in 2 quarters. The position peaked at $3K in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Thompson Davis & Co reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Thompson Davis & Co sold 250 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $3K.
Thompson Davis & Co first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
Thompson Davis & Co's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $3K in Q3 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Thompson Davis & Co's 13F filing for Q4 2014, filed 6 Feb 2015.